SCHEMBL1728558

SCHEMBL1728558

CCCCCCCCCCCCCCCCCCCCCC(=O)OCCO

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.80
MGLL Q99685 1/20 0.65
DNM1 Q05193 1/20 0.65
PAM P19021 2/20 0.60
LMNA P02545 2/20 0.58
KDM4E B2RXH2 1/20 0.58
DUSP3 P51452 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
MAPT P10636 2/20 0.56
TSHR P16473 1/20 0.56
PRSS1 P07477 1/20 0.56
PRSS2 P07478 1/20 0.56
PRSS3 P35030 1/20 0.56
NAAA Q02083 1/20 0.55
ALDH1A1 P00352 1/20 0.55
PRKCA P17252 1/20 0.54
PRKCE Q02156 1/20 0.54
PRKCQ Q04759 1/20 0.54
PRKCD Q05655 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168967 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL3504195 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL3505311 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL3503192 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL825306 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL1443883 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL2530608 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL10412 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL406849 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA
SCHEMBL19821319 1.00 DGKA (0.80) DGKAMGLLDNM1PAMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112147859-B Toner and method for producing the same 佳能株式会社 2024-07-26 CN claimed
US-11357712-B2 Method of use and compositions LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2022-06-14 US claimed
CN-109535287-A A kind of external electron donor of propylene polymerization catalyst, propylene polymerization catalyst system and the preparation method and application thereof 锦州英诺威科技服务有限公司 2019-03-29 CN claimed
US-20030215498-A1 Rapidly disintegrating comressed tablets comprising biologically active compounds GATTEFOSSE CORPORATION 2003-11-20 US claimed
US-20250370361-A1 IMAGE FORMING METHOD KONICA MINOLTA INC (JP) 2025-12-04 US disclosed
EP-4650387-A1 LOW-SUBSTITUTED CELLULOSE ETHER SPHERICAL MICROPARTICLE, COSMETIC COMPOSITION USING THE SAME, AND METHOD OF PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD., (JP) 2025-11-19 EP disclosed
US-20250345262-A1 LOW-SUBSTITUTED CELLULOSE ETHER SPHERICAL MICROPARTICLE, AND COSMETIC COMPOSITION USING THE SAME, AS WELL AS METHOD OF PRODUCING LOW-SUBSTITUTED CELLULOSE SPHERICAL MICROPARTICLE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-11-13 US disclosed
EP-4644996-A2 IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2025-11-05 EP disclosed
CN-113677337-B Cationic compositions based on self-neutralizing amino acids 伊诺莱克斯投资公司 2025-05-23 CN disclosed
CN-113373687-B Treating agent for artificial silk ear and artificial silk ear using the same 三吉油脂株式会社 2025-02-18 CN disclosed
US-20240327709-A1 NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF FARNEX CORPORATION (JP) 2024-10-03 US disclosed
CN-112147859-B Toner and method for producing the same 佳能株式会社 2024-07-26 CN disclosed
US-6645475-B2 For controlling or preventing perspiration UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-11-11 US disclosed
CN-1433301-A Novel formulation for inhibiting ethylene response in plants, method for preparing same and method for using same LYTONE ENTPR INC (CN) 2003-07-30 CN disclosed
US-20030086884-A1 ANTIPERSPIRANT FORMULATIONS UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-05-08 US disclosed
WO-2003005976-A2 ANTIPERSPIRANT FORMULATIONS UNILEVER PLC (GB) 2003-01-23 WO disclosed
CN-1385457-A Gel composition PANRICO PARTNERSHIP INC (US) 2002-12-18 CN disclosed
EP-1262318-A2 Lithographic printing plate precursor Fuji Photo Film Co., Ltd. (JP) 2002-12-04 EP disclosed
CN-1348815-A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use TIANJIN TIANSHILI PHARMACEUTIC (CN) 2002-05-15 CN disclosed
US-5248333-A MIXTURES OF FATTY ACID ALKYLENE DIAMIDES, FATTY ACID ESTERS AND METAL SOAPS, AND THEIR USE AS ADDITIVES IN PLASTICS NEYNABER CHEMIE GMBH (DE) 1993-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11357712-B2 Method of use and compositions CUTA, MGLL, PLIN5 DGKA 19/4885MGLL 2/4885DNM1 1065/4885
US-20240327709-A1 NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF ELOVL1, ELOVL5, ELOVL3 DGKA 231/4885MGLL 29/4885DNM1 1376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.